<!DOCTYPE html>

<html>
  <head>
    <title>BCNscreening</title>
    <meta charset="utf-8" />
    <meta
      name="viewport"
      content="width=device-width, initial-scale=1, user-scalable=no"
    />
    <link rel="stylesheet" href="assets/css/main.css" />
  </head>
  <body class="is-preload">
  
    <div id="page-wrapper">
      <!-- Wrapper -->
      <div class="wrapper">
        <div class="inner">
          <!-- Header -->
          <header id="header">
            <span class="miga"><a href="index.html"
              ><span class="depan">MÓDULO 6</span>&nbsp;</a
              ><span><a href="M6biblio.html"
                ><i class="arrow right"></i>&nbsp;&nbsp;<span class="depan">Bibliografía</span></a></span></span>
            <nav>
              <ul>
                <li><a href="#menu"></a></li>
              </ul>
            </nav>

          </header>

          <!-- Nav -->

          <nav id="menu">
            <h4>ÍNDICE</h4>

            <ul class="links">
              <li><a href="M61_1.html">&nbsp;Unidad 1</a></li>
              <li><a href="M62_1.html">&nbsp;Unidad 2</a></li>
          
            </ul>
            <h4>RECURSOS</h4>
            <ul class="links">
              <li><a href="M6summary.html">&nbsp;Resumen</a></li>
              <li><a href="M6biblio.html">&nbsp;Bibliografía</a></li>
              <li>
                <a href="docs/PDF_06.pdf" target="_blank"
                  >&nbspContenido en PDF</a
                >
              </li>
            </ul>
          </nav>
          <!-- Summary -->
          <section class="main">
            <header class="major">
              <h1>BIBLIOGRAFÍA</h1>
            </header>
                <ol class="alt">
                <li>Halloran ME, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997;146:789–803.
                </li>
                <li>Baussano I, Tshomo U, Tenet V, Heideman DAM, Wangden T, Franceschi S, et al. Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study. Annals of Internal Medicine 2020;
                </li>
                <li>Drolet M, Bénard É, Pérez N, Brisson M, HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 2019;394:497–509.
                </li>
                <li>Lehtinen M, Luostarinen T, Vänskä S, Söderlund-Strand A, Eriksson T, Natunen K, et al. Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III). Int J Cancer 2018;143:2299–310.
                </li>
                <li>Lehtinen M, Söderlund-Strand A, Vänskä S, Luostarinen T, Eriksson T, Natunen K, et al. Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I). Int J Cancer 2018;142:949–58.
                </li>
                <li>Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, et al. Vaccination protects against invasive HPV-associated cancers. Int. J. Cancer 2018;142:2186–7.
                </li>
                <li>Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. The New England Journal of Medicine 2020;383:1340–8.
                </li>
                <li>Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer. J Natl Cancer Inst 2021;
                </li>
                <li>Bray F, Laversanne M, Weiderpass E, Arbyn M. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int. J. Cancer 2020;
                </li>
                <li>Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol 2017;46:924–38.
                </li>
                <li>Kreimer AR, Chaturvedi AK, Alemany L, Anantharaman D, Bray F, Carrington M, et al. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncology 2020;108:104736.
                </li>
                <li>Rasmussen CL, Thomsen LT, Aalborg GL, Kjaer SK. Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination. Gynecol. Oncol. 2020;157:664–70.
                </li>
                <li>Meites E, Winer RL, Newcomb ME, Gorbach PM, Querec TD, Rudd J, et al. Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018. The Journal of Infectious Diseases 2020;
                </li>
                <li>Katz J. The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hospital-based population: A cross-sectional study of patient’s registry. J Oral Pathol Med 2020;
                </li>
                <li>Vänskä S, Luostarinen T, Baussano I, Apter D, Eriksson T, Natunen K, et al. Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. J Infect Dis 2020;222:948–56.
                </li>
                <li>Orumaa M, Kjaer SK, Dehlendorff C, Munk C, Olsen AO, Hansen BT, et al. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity. Vaccine 2020;38:1345–51.
                </li>
                <li>Stanley M, Joura E, Yen GP, Kothari S, Luxembourg A, Saah A, et al. Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines. Vaccine 2021;39:2214–23.
                </li>
                <li>Woestenberg PJ, Guevara Morel AE, Bogaards JA, Hooiveld M, van ’t Klooster TMS, Hoebe CJPA, et al. Partial protective effect of bivalent HPV16/18 vaccination against anogenital warts in a large cohort of Dutch primary care patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020;
                </li>
                <li>Challenges in the HPV Screening Landscape, Triage of Screening Positive Samples, and Screening in the Era of Vaccination | HPV Prevention and Control Board | University of Antwerp [Internet]. [cited 2021 May 13]; Disponible <a href="https://www.uantwerpen.be/en/projects/hpv-prevention-and-control-board/meetings/technical-meeting-august-2020/" class="" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span ></a>
                </li>
                <li>Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer 2020;123:510–7.
                </li>
                <li>WHO position paper 2017 [Internet]. [cited 2021 May 13]; Disponible <a href="http://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf;jsessionid=367FE82BC57A84F1B306E99CD359B8C0?sequence=1" class="" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span ></a> 
                </li>
                <li>Giorgi Rossi P, Carozzi F, Federici A, Ronco G, Zappa M, Franceschi S, et al. Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference. Prev Med 2017;98:21–30.
                </li>
                <li>Sultana F, Winch K, Saville M, Brotherton JML. Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination? Int J Cancer 2019;144:2964–71.
                </li>
                <li>Palmer TJ, McFadden M, Pollock KGJ, Kavanagh K, Cuschieri K, Cruickshank M, et al. HPV immunisation and cervical screening-confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study. Br. J. Cancer 2016;114:582–9.
                </li>
                <li>Lei J, Ploner A, Lehtinen M, Sparén P, Dillner J, Elfström KM. Impact of HPV vaccination on cervical screening performance: a population-based cohort study. Br J Cancer 2020;123:155–60.
                </li>
                <li>El-Zein M, Richardson L, Franco EL. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. J Clin Virol 2016;76 Suppl 1:S62–8.
                </li>
                <li>Franco EL. Screening of HPV vaccinated women [Internet]. HPW: The newsletter on HPV2017 [cited 2021 Mar 26]; Disponible <a href="https://www.hpvworld.com/articles/screening-of-hpv-vaccinated-women" class="" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span ></a> 
                </li>
                <li>Giorgi-Rossi P, Franceschi S, Ronco G. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer 2012;130:1387–94.
                </li>
                <li>Inturrisi F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, Ronco G, Meijer CJLM, et al. Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer. Int. J. Cancer 2020;
                </li>
                <li>Simms KT, Smith MA, Lew J-B, Kitchener HC, Castle PE, Canfell K. Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. Int J Cancer 2016;139:2771–80.
                </li>
                <li>Habbema D, Weinmann S, Arbyn M, Kamineni A, Williams AE, M C M de Kok I, et al. Harms of cervical cancer screening in the United States and the Netherlands. Int J Cancer 2017;140:1215–22.
                </li>
                <li>Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst 2017;109.
                </li>
                <li>Landy R, Windridge P, Gillman MS, Sasieni PD. What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study. Int J Cancer 2018;142:709–18.
                </li>
                <li>Pedersen K, Burger EA, Nygård M, Kristiansen IS, Kim JJ. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines. Eur J Cancer 2018;91:68–75.
                </li>
                <li>Baussano I. HPV-16 Infection and Cervical Cancer : A dynamic model [Internet]. 2010 [cited 2021 May 13]; Disponible <a href="https://ethos.bl.uk/OrderDetails.do?did=1&uin=uk.bl.ethos.526378" class="" target="_blank">aquí <span class="icon solid fa-external-link-alt"></span ></a>
                </li>
                <li>Louvanto K, Eriksson T, Gray P, Apter D, Baussano I, Bly A, et al. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer 2020;147:440–7.
                </li>
                <li>Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, et al. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Prev Med 2019;118:44–50.
                </li>
                <li>Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020;24:102–31.</li>
               

















                </ol>
              <hr />
    <!-- Section -->
    <section class="main">
      <header class="major">
        <h2>MÓDULO 6:</h2>
      </header>
      <div class="featuresC">
        <section>
          <a href="M61_1.html"
            ><span class="icon solid fa-syringe major accent4"></span
          ></a>
          <h3><a href="M61_1.html" class="button">UNIDAD 1</a></h3>
          <a href="M61_1.html"><p>Impacto de la vacunación contra el VPH</p></a>
        </section>
        <section>
          <a href="M62_1.html"
            ><span class="icon solid fa-microscope major accent4"></span
          ></a>
          <h3><a href="M62_1.html" class="button">UNIDAD 2</a></h3>
          <a href="M62_1.html"><p>Cribado sistemático del cáncer de cuello uterino</p></a>
        </section>
       
      </div>
      <hr />

        <header class="major">
          <h2>RECURSOS</h2>
        </header>
        <div class="featuresA">
          <section>
            <a href="M6summary.html"
              ><span class="icon solid fa-star major accent4"></span
            ></a>
            <h3><a href="M6summary.html" class="button">Resumen</a></h3>
          </section>
          <section>
            <a href="M6biblio.html"
              ><span class="icon solid fa-book major accent4"></span
            ></a>
            <h3><a href="M6biblio.html" class="button">Bibliografía</a></h3>
          </section>
          <section>
            <a href="docs/PDF_06.pdf" target="_blank"
              ><span class="icon solid fa-file major accent4"></span
            ></a>
            <h3>
              <a href="docs/PDF_06.pdf" target="_blank" class="button"
                >PDF</a
              >
            </h3>
          </section>
        </div>
        
      </section>
    </div>
  </div>


   <!-- Wrapper -->
   <div class="wrapper">
    <div class="inner">
      <!-- Footer -->
      <footer id="footer">
        <div class="image">
          <a href="https://www.e-oncologia.org/" target="_blank"><img src="images/logos.png" alt="" data-position="" /></a>
        </div>
      </footer>
    </div>
  </div>
</div>

<!-- Scripts -->
<script src="assets/js/jquery.min.js"></script>
<script src="assets/js/browser.min.js"></script>
<script src="assets/js/breakpoints.min.js"></script>
<script src="assets/js/util.js"></script>
<script src="assets/js/main.js"></script>
</body>
</html>